philly.com — The Supreme Court spared pharmaceutical companies a big expense in its Monday ruling against former sales representatives for GlaxoSmithKline, who sued to get paid for overtime. The reps worked for GSK's predecessor, SmithKline Beecham, but GSK inherited the litigation. "The numbers would have been gigantic," said University of Michigan business professor Erik Gordon, who keeps track of the pharmaceutical industry.